Home' Australian Pharmacist : Australian Pharmacist March 2013 Contents Australian Pharmacist March 2013 I ©Pharmaceutical Society of Australia Ltd. 79
Eli Lilly Australia
Axiron is a new testosterone replacement
therapy applied to the underarm -- used
as directed, the risk of transference is
localised to the axilla.1,2
• Effectively restored physiological
testosterone levels (10.4-36.4 nmol/L)
in 76% of men with androgen
deficiency at day 151
• Maintained mean serum testosterone
level within the normal range over
• According to the Short Form-36 (SF-36)
survey, significantly improved general
physical and mental wellbeing vs
baseline. According to the Psychosocial
Daily Questionnaire (PDQ), at day 120,
AXIRON patients reported increased:3
-- Sexual desire (p<0.0001)
-- Overall sexual activity (p<0.0001)
-- Positive and negative mood
-- Plus, satisfactory erection
Axiron is designed to fit into a man's
daily life.1 It is indicated for confirmed
testosterone deficiency in males. It can
be applied two minutes after deodorant
and dries fragrance free in approximately
three minutes.1 Axiron patients can wash
or swim two hours after application.1
The recommended time for testosterone
gel patients to wait before showering is
1. AXIRON Product Information, May 2012.
2. Acrux patent (data on file).
3. Wang C et al. Clin Endocrinol 2011:75:836--43.
4. Testogel Product Information, Feb 2011.
5. Testogel Consumer Product Information.
The Gaviscon relief program
The Gaviscon relief program is a new
in-pharmacy clinical intervention
program developed by Reckitt Benckiser
to assist pharmacists to better manage
patients with gastro-oesophageal
reflux disease (GORD). It is supported
by the Pharmacy Guild of Australia.
The program recognises the important
role pharmacists play in primary care, and
encourages them to identify patients who
are currently on acid-suppressive therapy
(such as PPIs) and experience occasional
'breakthrough' heartburn symptoms, and
talk to them about options for relief.
With one in three people on prescription
heartburn medication still experiencing
occasional 'breakthrough' heartburn
symptoms,1,2 there is a significant
opportunity for pharmacists to improve
patient care and engage with persons
with GORD and heartburn. Many patients
with GORD/Reflux are self-medicating and
there is often minimal HCP intervention in
any treatment decision.
The Gaviscon relief program has of
• Education -- attend the Pharmacy
interventions: Gord matters educational
meeting or complete the online
OCEANIA UNIVERSITY OF MEDICINE
NOW INTERNATIONALLY ACCREDITED
For more information visit www.oceaniamed.org or 1300 665 343
You're smart and successful, but is Pharmacy meeting your expectations?
You know the science. Now get the clinical skills to become a physician.
No need to uproot family and move from friends and support systems
Continue working during first two years
-- OUM graduates are eligible to sit for the AMC exam
-- New classes begin every January and August.
BPharm to MBBS
• Intervention -- participate in the in-
pharmacy intervention program
• Assessment -- Complete post-program
The education modules available to
pharmacists include uncovering the
symptoms of heartburn; indications
for GORD and escalating therapy; and
recognising breakthrough symptoms
on-treatment. The program also covers
pharmacist education on the mechanical
model of gastro-oesophageal reflux,
and current thinking that excessive acid
production is no longer seen as the sole
cause of reflux but a contributor. This
new school of thought highlights the
importance of a physical barrier between
the acid pocket (the layer of highly acidic
content on the top of the stomach)
and the lower oesophageal sphincter.
The program also provides patient
screening tools and materials that will
help pharmacists identify patients who
are suitable for this clinical intervention.
1. Donnellan C, et al. The Cochrane Library 2009. Issue 1.
2. El-Serag H, et al. Alimentary Pharmacology & Therapeutics
Links Archive February 2013 Australian Pharmacist April 2013 Navigation Previous Page Next Page